Search results
Author(s):
Usha Krishnan
Added:
3 years ago
Pediatric interventional cardiology was born 40 years ago in 1966, when William Rashkind developed balloon septostomy in neonates with transposition of the great arteries.1 Almost a decade later, Andreas Gruentzig developed coronary angioplasty (between 1972 and 1976), which heralded an explosive era of interventional therapy for adults with heart disease, overshadowing the advances in…
View more
Coarctation: A Review
Author(s):
Marc G Cribbs
Added:
3 years ago
Article
Author(s):
Jacob Green
,
Vasilis Babaliaros
,
Peter Block
Added:
3 years ago
Mitral regurgitation (MR) is the most prevalent form of valvular heart disease. Its major causes are primary mitral leaflet abnormalities (valve prolapse, healed endocarditis, or rheumatic disease), primary myocardial disease (functional MR), and ischemic disease. Even with severe MR, affected individuals may remain asymptomatic for long periods of time.1 The early, compensated state of MR is…
View more
Author(s):
Duraisamy Balaguru
,
Rajiv Verma
Added:
3 years ago
Surgical repair has been the cornerstone of treatment for congenital heart diseases (CHD). However, cardiac catheterization has evolved from being a diagnostic modality to a therapeutic one in the past four decades. Application of catheter-based therapy has become the standard of care for some congenital heart defects, thus obviating surgery. This review will discuss congenital heart defects that…
View more
Author(s):
Michael N Young
,
Sammy Elmariah
Added:
3 years ago
Severe aortic valve stenosis (AS) is chronic, progressive illness that confers significant morbidity and mortality. Once symptomatic, patients with severe AS will ultimately succumb to the disease if it is not promptly corrected.1 Historically, surgical aortic valve replacement (SAVR) served as the exclusive therapeutic option to correct this mechanical problem.2 However, in 2002, Alain Cribier…
View more
Author(s):
Eden C Payabyab
,
Lindsay S Elbaum
,
Navneet Sharma
,
et al
Added:
2 years ago
Author(s):
Trevor J Simard
,
Mackram F Eleid
Added:
2 years ago
Author(s):
Nils Perrin
,
Anita W Asgar
Added:
2 years ago
Author(s):
Somsupha Kanjanauthai
,
Kabir Bhasin
,
Luigi Pirelli
,
et al
Added:
3 years ago
Transcatheter aortic valve replacement (TAVR) has been established as a therapeutic option for patients with severe symptomatic aortic stenosis who are considered to be of intermediate, high or prohibitive surgical risk.1–5 As a result of favorable TAVR outcomes and substantial improvements in transcatheter heart valve (THV) technologies and implantation techniques, the feasibility of broadening…
View more
Author(s):
Ahmad Younes
,
Guilherme Ferragut Attizzani
,
Ankur Kalra
Added:
3 years ago
Transcatheter aortic valve replacement (TAVR) is a recent innovation that has transformed the care of patients with symptomatic severe aortic stenosis. It has emerged as an alternative for surgical aortic valve replacement (SAVR) in prohibitive-, high-risk, and more recently, intermediate-risk surgical patients. More than 200,000 TAVRs have been performed in 65 countries around the world.1
As…
View more